2018 International Congress Archives - Page 50 of 177

Early cortical signature of development of visual hallucinations in ‘de novo’ Parkinson’s disease

H. Bejr-kasem, J. Pagonabarraga, S. Martínez-Horta, F. Sampedro, J. Marin-Lahoz, A. Horta-Barba, I. Aracil-Bolaños, J. Perez-Perez, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)
Early Experiences with Entrainment by Transcranial Alternating Current Stimulation in Patients with Essential Tremor

F. Maguire, T. Munteanu, A. Khatoun, M. Mc Laughlin, T. Lynch, R. Reilly (Dublin, Ireland)
Early gastrointestinal dysfunction is predictive of faster progression in Parkinson’s disease

M. Camacho, J. Evans,, D. Breen, G. Cummins, R. Wijeyekoon, K. Scott, T. Stoker, R. Barker, C. Williams-Gray (Cambridge, United Kingdom)
Early stage Parkinson’s disease phenotypes

J. Toledo, MC. Rodriguez-Oroz, W. Ondo (Houston, TX, USA)
Early synaptic loss and synaptic instability in a mouse model of prodromal Parkinson’s disease

Y. Hatanaka, R. Takahashi (Kyoto, Japan)
Early-onset Parkinson’s disease in seven patients with heterozygosity for parkin mutation

C. Lima, A. Novo, M. Sousa, M. Almeida, A. Morgadinho, C. Januário (Coimbra, Portugal)
Early-onset parkinsonism and epilepsy: A Tunisian family carrying a novel SYNJ1 mutation

S. Ben Romdhan, R. Zouari, S. Sakka, N. Farhat, O. Hdiji, H. Haj Kacem, M. Dammak, C. Mhiri (Sfax, Tunisia)
Economic burden of advanced Parkinson’s disease in a national sample of elderly US Medicare beneficiaries: A prevalence-based estimate

N. Dahodwala, P. Li, J. Jahnke, V. Ladage, P. Kandukuri, J. Zamudio, Y. Bao, Y. Jalundhwala, J. Doshi (Philadelphia, PA, USA)
Economics of Botulinum Toxin Therapy: Influence of the AbobotulinumtoxinA Package Size on the Costs of Botulinum Toxin Therapy

F. Adib Saberi, D. Dressler (Hamburg, Germany)
Educating Movement Disorders through a web based counselling service in Mauritius

M. Busgopaul (Port Louis, Mauritius)
Education in hyperkinetic movement disorders in Cameroonian health providers

M.H.G. Monje, M.M. Kurtis, M. Molina, C. Delgado-Suárez, P. Gómez-Iglesias, I. García-Morales, D. García-Azorín (Móstoles, Madrid, Spain)
eEF1A2 and Prdx1 as possible new targets for Parkinson’s disease therapeutics

W. Wirakiat, P. Dharmasaroja (Bangkok, Thailand)
EEG microstates changes in response to increase in dopaminergic stimulation in treated typical Parkinson’s disease patients without clinical fluctuations

V. Cortés, I. Serrano, N. Mendes, M. Del Castillo, A. Arroyo, J. Andreo, M. Del Valle, J. Herreros, JP. Romero, (Madrid, Spain)
Effect of Ba Duan Jin Exercise on Non-Motor Symptoms, Motor Symptoms, Gait and Balance in Patients with Mild to Moderate Parkinson’s Disease

Z. Cai, S. Dong (Lianyungang City, China)
Effect of bedtime levodopa/carpidopa/entacapone (Stalevo®) on sleep disturbance in patients with Parkinson’s disease with motor fluctuation

KW. Park, HS. Ryu, MS. Kim, NR. Choi, SJ. Chung (Seoul, Republic of Korea)
Effect of CDNF on non-motor symptoms like motivation, fear, stress and depression-like behavior

P. Stepanova, M. Voutilainen, E. Laakkonen, M. Airavaara, V. Voikar, P. Piepponen, R. Tuominen, M. Saarma (Helsinki, Finland)
Effect of Cold Compression Before Botulinum Neurotoxin Injection in Hemifacial Spasm

P. Dhanachanvisith, T. Tantirittisak (Bangkok, Thailand)
Effect of COMT-inhibitor in the clinical progression of Parkinson’s disease

I.U. Song, K.S. Lee, Y.A. chung (Incheon, Republic of Korea)
Effect of deep brain stimulation on clinical outcome in Parkinson’s disease patients with different genetic status

M. Kestenbaum, R. Schvartz, Y. Balash, A. Hilel, A. Mirelman, N. Giladi, T. Gurevich (Tel Aviv, Israel)
Effect of different normative samples and cut-off values on determination of cognitive impairment in the Parkinson’s Progression Marker Initiative

K. Wyman-Chick, D. Weintraub, P. Martin, L. Erickson, M. (Saint Paul, MN, USA)
Effect of dopamine agonists versus levodopa as initial treatment in Parkinson’s Disease

J. Chen, J. Hong, L. Chunfeng (Suzhou, China)
Effect of dual task as rehabilitation therapy in Parkinson’s disease in the UPDRS III

C. Mejia (Lima, Peru)
Effect of exercise on neurodegenerative parkinsonism unmasked by dopamine blocking drugs (DRBD)

J. Morley, S. Wood, G. Cheng, K. Browne, K. Robinson, D. Weintraub, J. Duda (Philadelphia, PA, USA)
Effect of finger rhythmic movement training on freezing of gait in Parkinson’s disease patients: A study protocol

H. Nakano, S. Murata, T. Kodama, H. Nakae, M. Soma (Kyoto-city, Japan)
Effect of Glucocerebrosidase enzymatic activity on neural activation during a cognitive task in Parkinson’s disease patients

M. Ramezani, J.S. Provost, N. Auclair-Ouellet, I. Kathol, A. Hanganu, M. Kibreab, J. Cheetham, T. Hammer, L. Derwent, A. Robichaud, R. Chiang, J. Sarna, SP. Sardi, O. Monchi (Calgary, AB, Canada)
Effect of levodopa on fronto-parietal network connectivity in freezing of gait in Parkinson’s disease

B. Bluett, E. Bayram, S. Banks, X. Zhuang, V. Mishra, Z. Yang, C. Bird, D. Cordes, Z. Mari, I. Litvan, K. Sreenivasan (Las Vegas, NV, USA)
Effect of lidocaine injection into the external oblique muscle on camptocormia and the lateral slant posture in patient with Parkinson’s disease

Y. Higashi, M. Tabata, T. Tabuchi, Y. Hattori (Himeji, Japan)
Effect of medication on lexical tone production in Cantonese patients with Parkinson’s Disease

A. Chan, S. Chen, J. Shao, C.C. Zhang, I. Lam, S. Pang, V. Ngan, J. Tam, W.C. Yang, J. Ngan, S. Pinto (Hong Kong)
Effect of mindfulness yoga on psychological distress in people with Parkinson’s disease (PD): A randomized controlled trial

J.Y.Y. Kwok, J.C.Y. Kwan, M. Auyeung, C.T. Mok, C.K.Y. Lau, H.Y.L. Chan (New Territories, Hong Kong)
Effect of multiple sessions of transcranial direct current stimulation in Writer’s cramp: Does it hold promise?

S. Jaiswal, S. Choudhury, S. Halder, M. Baker, S. Baker, H. Kumar (Kolkata, India)
Effect of PD medication on disease progression as measured by rate of change in MDS_UPDRS and DaT SBR in PPMI study

J. Cedarbaum, K. Evans, M. Yang, J. Xiao (Cambridge, MA, USA)
Effect of Post-Operative Symptomatic Lead Edema Associated with Subthalamic Deep Brain Stimulation On Clinical Outcomes

V. Sharma, K. Lyons, J. Nazzaro, R. Pahwa (Kansas City, KS, USA)
Effect of striatal dopamine depletion on cognition in de novo Parkinson’s disease

H. Jeong, S. Chung, J. Oh, J. Kim, P. Lee (Seoul, Republic of Korea)
Effect of Thalamic Deep Brain Stimulation in Isolated Dystonia Associated with Prominent Tremor

J. Choi, S. Heath, D. Wang, P. Starr, P. Larson, D. Lim, M. San Luciano, M. Volz, J. Ostrem (San Francisco, CA, USA)
Effect of Urinary Dysfunction on Fatigue Syndrome in Parkinson’s disease

V. Datieva, O. Levin (Moscow, Russian Federation)
Effect of Viewpoint and Visual Texture on Object Recognition in Dementia with Lewy Bodies and in Alzheimer’s Disease

Y. Oishi, K. Suzuki, T. Imamura, T. Shimomura (Niigata, Japan)
Effective physiotherapy program for Parkinson’s disease

I. Toyoshima, K. Hasegawa, M. Doi (Yurihonjo, Japan)
Effective Tools for Mild Cognitive Impairment Level I Criteria of Movement Disorder Society: Utility of Screening Tests and Their Interconversion

RL. Yu, WJ. Lee, JY. Li, YY. Chang, CC. Chen, JJ. Lin, YF. Sung, TK. Lin, RS. Chen, YH. Yang, YW. Yang, SJ. Wang, JL. Hsu, HC. Wang, JL. Fuh (Tainan, Taiwan)
Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: A retrospective analysis of medical claims data

J. Ypinga, N. de Vries, L. Boonen, X. Koolman, M. Munneke, A. Zwinderman, B. Bloem (Tilburg, Netherlands)
Effectiveness and safety of acupuncture in the treatment of Parkinson’s disease: A systematic review and meta-analysis of randomized controlled trials

CN. Ko, SU. Park, SY. Cho, JM. Park (Seoul, Korea)
Effectiveness of a Multi-disciplinary Parkinson’s Disease (PD) Clinic: A 2-year Prospective Observational Study

G. Chan, N. Cheung, S. Or, I. Chan, A. Leung, C. Li, D. Chau, C.W. Woo, B. Chee, W.C. Fong (Hong Kong)
Effectiveness of an Activity-based Integrative Group Therapy (ParkEASE) on Health-Related-Quality of Life of People with Parkinson’s Disease and of their Caregivers: A Retrospective Pilot Study

D. Tsang, R. Wong, C. Lau, A. Chan, D. Chan, X.L. Zhu, W.S. Poon, V. Mok (Hong Kong, Hong Kong)
Effectiveness of Occupational Therapy (OT) Multi-modal group program for Parkinson’s patients at intermediate & advanced stage in improving quality of life (QoL) & relieving carer’s stress

R. Wong, D. Tsang, T. Tang, C. Lau, A. Chan, D. Chan, X.L. Zhu, W.S. Poon, V. Mok (Hong Kong, Hong Kong)
Effectiveness of peloid therapy in management of Parkinson’s disease (PD): A single center experience

C.S. Khoo, E. Tokareva, O. Rybalko, I. Sukhareva (Cheras, Malaysia)
Effectiveness of Rotigotine plus Intensive and Goal-based Rehabilitation versus Rotigotine alone in “de-novo” Parkinsonian subjects: A Randomized Controlled Trial with 18-month Follow-up

D. Ferrazzoli, P. Ortelli, G. Riboldazzi, R. Maestri, G. Frazzitta (Gravedona ed Uniti, Italy)
Effects of a combined approach with botulinum toxin (BONT) and motor-learning techniques (MLT) on sensori-motor functional connectivity in patients with cervical dystonia (CD)

A. Castagna, M. Cabinio, M. Ramella, L. Magistrelli, M. Laganà, F. Baglio (Milano, Italy)
Effects of age, motor severity and disease duration on finger tapping movement under dual-task in Parkinson’s disease patients

A. Miyake, T. Yamamoto, H. Kawasaki, N. Tamura, N. Araki (Saitama prefecture, Japan)
Effects of Aquatic Physical Therapy on Parkinson’s disease under a vision of the International Classification of Functioning, Disability and Health (ICF)

V. Israel, B. Yamaguchi, M. Ferreira (Curitiba, Brazil)
Effects of balance training in patients with cervical dystonia

J. Richter, C. Weise, A. Villringer, P. Ragert, D. Weise (Leipzig, Germany)
Effects of Botulinum Toxin treatment for sialorrhea in patients with cerebral palsy

J. Francês Brito, M. Akkari, A. Pinheiro Alves, A. Barbosa de Sousa Junior, B. De Oliveira, O. Vieira Kishi, Jose Roberto Bentes Capeloni (Belem, Brazil)
Effects of computerized cognitive training, with and without concurrent exercise, on executive functions in Parkinson’s disease

M. Fernandez-del-Olmo, JA. Sánchez-Molina, H. Fernandez-Lago, L. Morenilla-Burlo, J. Gómez-Varela, N. Fogelson (A Coruña, Spain)
Effects of droxidopa when measuring gait speed, kyphosis, and functional reach in Parkinson’s disease

C. Kutz, L. Adams, E. Moncheski (Colorado Springs, CO, USA)
Effects of Expiratory Muscle Strength Training and Voice Therapy on Parkinsonian Speech

T.S. Tong, M.W. Ng (Pokfulam, Hong Kong)
Effects of Glial Heme Oxygenase-1 on Neuronal Alpha-Synuclein in the GFAP.HMOX1 Mouse Model of Parkinson’s Disease

M. Cressatti, W. Song, A. Turk, C. Galindez, H. Schipper (Montreal, QC, Canada)
Effects of High-frequency Repetitive Transcranial Magnetic Stimulation (HF-rTMS) Combined with Task Specific Training in Individuals with Parkinson’s Disease

J. Thanakamchokchai, J. Tretriluxana, B. Fisher, N. Pakaprot, A. PisarnPong (Nakhon Pathom, Thailand)
Effects of Intensive Voice and Articulation Treatments on Voice Quality in Parkinson’s disease

J. Spielman, L. Ramig, K. Freeman, A. Halpern, Y. Maryn (Denver, CO, USA)
Effects of JN403, an α-7-nicotine-acetylcholine-receptor (α7-nAChR) agonist on human alpha-synuclein-mediated in vitro and in vivo models of Parkinson’s disease

B. Lee, C. Noelker, W. Chiu, D. Feuerbach, L. Timmerman, W. Oertel (Marburg, Germany)
Effects of Korean Medicine on Postural Instability and Gait Difficulty in Patient with Parkinsonism

HM. Lee, SB. Yang, SY. Cho, JM. Park, CN. Ko, SU. Park (Seoul, Republic of Korea)
Effects of L-DOPA on Quantitative Gait Parameters Measured with Wearable Sensors

M. Brys, J. Paskavitz, A. Dowling, V. Auclair, A. Wood, D. McLaren, R. Postuma, B. Bedell, J. Cedarbaum (Cambridge, MA, USA)
Effects of Long-Term Valbenazine on Tardive Dyskinesia by Body Region: Shift Analyses of KINECT 4 Study Results

C. Comella, C. Singer, S. Marder, J. Burke, K. Farahmand, R. Jimenez, S. Siegert (Chicago, IL, USA)
Effects of mannitol treatment in a mice model of multiple system atrophy (MSA)

N. Lev, Y. Barhum (Kfar Saba, Israel)
Effects of MRI-guided Focused Ultrasound unilateral subthalamotomy on characteristics of EMG activity underlying reaction time and tapping test in Parkinson’s disease

D. Urso, B. Fernández-Rodríguez, R. Rodríguez-Rojas, M. del Álamo, F. Hernández-Fernández, J. Pineda-Pardo, M. Dileone, G. Foffani, I. Obeso, C. Gasca-Salas, L. Vela, R. Martínez-Fernández, F. Alonso-Frech, J. Obeso (Móstoles, Spain)
Effects of multi-session repetitive transcranial magnetic stimulation on performance of motor control and dynamics of spontaneous brain activity in multiple system atrophy

Z. Liu, H.Z. Ma, X.M. Wang, Z. Wang, Y.Q. Wang, J.H. Zhou, T. Feng (Beijing, China)
Effects of N-methyl-D-aspartate receptor antagonist in Parkinson’s disease with dementia

Y. Chung, I. Song, L. Lee (Incheon, Republic of Korea)
Effects of neural stem cell transplantation on the differentiation of dopaminergic neurons in the substantia nigra and changes to rotational behavior of Parkinson’s disease rats

J.J. Xiao, X.P. Wang (Shanghai, China)
Effects of non-invasive brain stimulation on motor-speech disorders in Parkinson’s disease

I. Rektorova, P. Klobusiakova, L. Brabenec, J. Mekyska, Z. Galaz, M. Kostalova (Brno, Czech Republic)
Effects of orthostatic hypotension and supine hypertension on cognition in Parkinson’s disease

H. Jeong (Changwon, Republic of Korea)
Effects of PGE inhibition on Striatal Neuroinflammation in 6-OHDA lesion

T. Adu, M. Mabandla (Durban, South Africa)
Effects of progressive resistance and flexibility exercise program of trunk on static and dynamic stability for Parkinson’s disease

M. Lee, C. Youm, M. Son, H. Park, Y. Kim (Busan, Republic of Korea)
Effects of Rock Steady Boxing on Activities of Daily Living and Motor Symptoms of Parkinson’s Disease

D. Larson, D. Bega, E. Johnson, L. Slowey (Chicago, IL, USA)
Effects of rTMS on three cortical areas in Parkinson’s Disease

V. Goyal, P. Bhat, C. Goyal, A. Srivastava, S. Kumaran, M. Behari, S. Dwivedi (Delhi, India)
Effects of subthalamic nucleus deep brain stimulation in Parkinson’s disease are mediated by a prefronto-cerebellar-striatal loop

H. Hanssen, J. Steinhardt, A. Al-Zubaidi, A. Muenchau, M. Heldmann, P. Schramm, A. Neumann, D. Rasche, A. Saryyeva, J. Voges, I. Galazky, L. Buentjen, H. Heine, J. Krauss, V. Tronnier, T. Muente, N. Brueggemann (Luebeck, Germany)
Effects of the Lee Silverman Voice Treatment (LSVT LOUD ®) on Facial Expressivity in Individuals with Parkinson’s Disease (PD) as a function of Emotional Valence

A. Bono, K. Scorpio, R. Stafford, M. Halfacre, E. Murray, J. Twaite, K. Alterescu, J. Spielman, A. Halpern, L. Ramig, J. Borod (Flushing, NY, USA)
Efficacy and safety of combined unilateral subthalamic nucleus and contralateral globus pallidus deep brain stimulation in Parkinson’s disease

N.R. Choi, K.W. Park, H.S. Ryu, M.S. Kim, S.J. Chung (Seoul, Republic of Korea)
Efficacy and safety of Rasagiline in treatment of gait disturbances in dementia with Lewy bodies

A. Chimagomedova, O. Levin, M. Anikina, I. Ayzenberg (Moscow, Russian Federation)
Efficacy and safety of safinamide as a levodopa adjunct in patients with parkinson disease and motor fluctuations: A systematic review of randomized controlled trials

S. Hussain, A. Najmi (New Delhi, India)
Efficacy and security starting safinamide treatment with 100 mg/day in PD

N. Foncea (Galdakao, Spain)
Efficacy of combined treatment with acupunture and bee venom acupuncture for Parkinson’s disease: Double blind randomized controlled trial

S.U. Park, H.M. Lee, S.Y. Cho, J.M. Park, C.N. Ko (Seoul, Republic of Korea)
Efficacy of CVT-301 (levodopa inhalation powder) for treatment of OFF periods in Parkinson’s disease

R. Pahwa, I. Abeynayake, M. Klingler, A. Sedkov, C. Kenney, C. Oh (Overland Park, KS, USA)
Efficacy of incobotulinumtoxinA in patients with sialorrhea, as assessed using the modified Radboud Oral Motor Inventory for Parkinson’s disease (mROMP): Results of the SIAXI study

W. Jost, A. Friedman, O. Michel, C. Oehlwein, J. Slawek, A. Bogucki, S. Ochudlo, M. Banach, F. Pagan, B. Flatau-Baqué, J. Csikós, A. Blitzer (Wolfach, Germany)
Efficacy of liquid sinemet on non-motor symptoms in Parkinson’s disease

M. Danoudis, R. Iansek, C. Boon (Cheltenham, Australia)
Efficacy of multidisciplinary care in people with Parkinson’s disease: A systematic review and meta-analysis

S. Balakrishnan, D. Tan (Singapore)
Efficacy of ND0612 for nocturnal problems and early morning OFF

F. Stocchi, W. Poewe, T. Rachmilewitz Minei, S. Oren, R. Case, K. Kieburtz, C. Olanow (Rome, Italy)
Efficacy of opicapone in Parkinson’s disease patients with ‘early’ motor fluctuations: NMSS analysis from the BIPARK-I double-blind experience

A. Antonini, J. Ferreira, W. Poewe, O. Rascol, H. Gama, E. Arbe, J-F. Rocha, P. Soares-da-Silva (Padova, Italy)
Efficacy of opicapone in Parkinson’s disease patients with ‘early’ motor fluctuations: Responder analyses from the BIPARK-I double-blind experience

J. Ferreira, A. Lees, W. Poewe, O. Rascol, A. Santos, E. Arbe, J-F. Rocha, P. Soares-da-Silva (Lisbon, Portugal)
Efficacy of opicapone in Parkinson’s disease patients with ‘early’ motor fluctuations: The BIPARK-I double-blind experience

J. Kulisevsky, E. Tolosa, J. Ferreira, A. Lees, H. Gama, E. Arbe, J-F. Rocha, P. Soares-da-Silva (Barcelona, Spain)
Efficacy of opicapone in Parkinson’s disease patients with ‘early’ motor fluctuations: UPDRS-II and III analysis from the BIPARK-I double-blind experience

G. Ebersbach, J. Ferreira, F. Stocchi, R. Costa, E. Arbe, J-F. Rocha, P. Soares-da- (Beelitz, Germany)
Efficacy of prolonged release melatonin for REM sleep behaviour disorder in Parkinson’s disease: A double blind, randomised, placebo-controlled trial

M. Gilat, R. Grunstein, N. Marshall, D. Hammond, A. Coeytaux Jackson, A. Mullins, J. Hall, S. (Sydney, Australia)
Efficacy of sublingual apomorphine film (APL-130277) for the treatment of OFF episodes in patients with Parkinson’s disease: Results from the Phase 3 double-blind, placebo-controlled trial

S. Factor, S. Isaacson, K. Sciarappa, P. Bhargava, G. Vakili, A. Agro, D. Blum, W. Olanow, B. Navia (Atlanta, GA, USA)
Efficacy of zonisamide on motor symptoms in dementia with Lewy bodies: A post-hoc analysis of a phase 3 study

H. Maruyama, M. Murata, T. Odawara, K. Hasegawa, R. Kajiwara, H. Takeuchi, K. Kosaka (Tokyo, Japan)
Electroglottographic(EGG) and Acoustic characteristics of voice in patients with Essential tremor(ET)

P A. Shetty, B K. Yamini, R. Yadav, N. Shivashankar, PK. Pal (Bangalore, India)
Electrophysiological characteristics of task-specific and position-specific tremor: A variant of dystonic tremor?

P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)
Electrophysiological characteristics of tremor in spinocerebellar ataxia type12 (SCA-12) and essential tremor (ET)

A. Srivastava, M. Narang, R. Rajan, G. Shukla, F. Mohammad, A. Pandit, D. Vibha, M. Singh, M. Srivastava, K. Prasad (New Delhi, India)
Elevated serum α-synuclein levels in Huntington’s disease patients

M. Breza, E. Emmanouilidou, G. Karadima, C.H. Kartanou, M. Panas, K. Vekrellis, G. Koutsis (Athens, Greece)
Emergency and in-patient healthcare utilization in Parkinson’s disease

M. Mackenzie, G. Al Momen, A. Yu, K. Sundvick, J. Wright, A. Shiu, S. Appel-Cresswell (Vancouver, BC, Canada)
Emotional Lability Following Deep Brain Stimulation Targeting Subthalamic Nucleus, Globus Pallidus Internus and Ventrointermedial Nucleus of Thalamus

S. Joza, T. Sankar, F. Ba (Edmonton, AB, Canada)
Emulating the natural timing of dopamine receptor activation in Parkinson’s Disease

J. Reynolds, B. Hyland, J. Wickens, E. Tan (Dunedin, New Zealand)
Encephalopathy in a Japanese patient with Rapid-Onset Dystonia-Parkinsonism carrying a Novel ATP1A3 mutation

K. Hoshino, T. Kawarai, M. Hayashi, K. Kimura, Y. Nagao, M. Fukumizu, R. Miyamoto, R. Kaji (Tokyo, Japan)
Enhanced cingulate activity while anticipating pain – evidence for altered ‘top down’ processing of pain in PD

S. Martin, A. Jones, C. Brown, C. Kobylecki, M. Silverdale (Manchester, United Kingdom)
Enhancing protein palmitoylation is protective in alpha-synuclein dependent cytotoxicity

G. Ho, T. Imberdis, S. Nuber, U. Dettmer, D. Selkoe (Boston, MA, USA)
Epidemiological and clinical profile of Parkinson’s disease in Douala

J. Doumbe, H. Bohongwe, Y. Mapoure, C. Kuate (Douala, Cameroon)
Epidemiological risk factors on cognition with PD patients in male: A cross-sectional study from southwest of China

Y. Wu, RW. Ou, H. Liu, QQ. Wei, XJ. Gu, Q. Han, LY. Zhang, W. Song, B. Cao, YP. Chen, B. Zhao, HF. Shang (Chengdu, China)
Epigenetic silencing in the humanized mouse model of Friedreich ataxia

L. Rodden, K. Gilliam, S. Bidichandani (Oklahoma City, OK, USA)
Erotophonophilia and severe impulse control disorder in a patient with Parkinson’s disease

C. vander Linden, H. Colle, D. Colle, J. Jankovic (Ghent, Belgium)
Estimates of cost and saving effects of increasing rechargeable devices on the sustainability of a deep brain stimulation program

Y. Compta, A. Cámara, P. Roldán, E. Muñoz, J. Rumià, MJ. Marti, F. Valldeoriola (Barcelona, Catalonia)
Evaluating long-term effectiveness of carbidopa/levodopa enteral suspension in advanced Parkinson’s Disease patients: PROviDE study design and baseline characteristics

R. Pahwa, R. Dorsey, P. Kandukuri, Y. Bao, J. Zamudio, I. Pan, Y. Jalundhwala (Kansas City, KS, USA)
Evaluating the clinical utility of the Parkinson’s KinetiGraph (PKG™) in the remote management of Parkinson’s disease

T. Dominey, L. Hutchinson, E. Pearson, F. Murphy, L. Bell, C. Carroll (Plymouth, United Kingdom)
Evaluating the impact of the educational course for nurses on Parkinson’s disease: A model for continuing nursing education

S. Phumphid, O. Jitkritsadakul, R. Bhidayasiri (Bangkok, Thailand)
Evaluating the Knowledge, Practice and Experience about Management of Parkinson’s Disease among Physiotherapists in Ghana: A Cross sectional Survey

M. Agoriwo (Accra, Ghana)
Evaluation clinical-biochemical features of Parkinson’s disease

D. Daminov, G. Rakhmatullaeva (Tashkent, Uzbekistan)
Evaluation of a driving questionnaire to facilitate awareness of issues that could compromise driving ability in a person with Parkinson’s disease

J. Price, H. Martin, L. Ebenezer (Powys, United Kingdom)
Evaluation of affective temperament and bipolarity among patients with Parkinson’ s disease

Y. Degirmenci, K. Altinbas, H. Kececi (Duzce, Turkey)
Evaluation of apathy before and after subthalamic nucleus deep brain stimulation therapy in advanced Parkinson’s disease patients

S. Caferova, O. Gönül, D. Gunal (Istanbul, Turkey)
Evaluation of Balance in Hereditary Ataxias

H. Teive, B. Zeigelboim, R. Santos, S. Dias, N. Mello, V. Fonseca (Cuitiba, Brazil)
Evaluation of bradykinesia in Parkinson’s disease using a computerised evolutionary algorithm

R. Newby, S. Muhamed, P. Kempster, J. Alty, S. Jamieson, J. Cosgrove, S. Smith (Leeds, United Kingdom)
Evaluation of Effectiveness and Safety of Botulinum Toxin Type-A (BTX-A) for Chronic Focal Post-Stroke Upper Limb Spasticity in Indian Stroke Patients

L. Basumatary (Guwahati, India)
Evaluation of impulsivity in Parkinson’ s disease

Y. Degirmenci, K. Altinbas, H. Kececi (Duzce, Turkey)
Evaluation of motor impulsivity in Huntington Disease with a choice reaction time task and brain metabolic (PET 18FDG) imaging

S. Grimaldi, E. Guedj, F. Fluchere, T. Hasbroucq, F. Vidal, JP. Azulay (Marseille, France)
Evaluation of non motor fluctuations in Parkinson disease by a visual analogue scale in Surgical Candidates

JPh. Azulay, C. Brefel-Courbon, C. Tranchant, F. Fluchere, A. Eusebio, M. Vaugoyeau, C. Magnaudet, T. Witjas (Marseille, France)
Evaluation of Non-motor Symptoms of Parkinson’s Disease Patients in a Hong Kong Chinese population using the HK-NMSQuest

V. Luk, N. Cheung, WC. Fong, G. Chan, A. Chan, KW. Fong, J. Lo, M. Ismail, J. Li, F. Chan, S. Chan, C. Chau, C. Ho, K.F. Leung, J. Lui, C. Wong, D. Chau, B. Chee, CW. Woo (Kowloon, Hong Kong)
Evaluation of pain in Parkinson’s disease

B. Durmus, O. Yilmaz Kusbeci, I. Inci (Izmir, Turkey)
Evaluation of Parkinson’s Disease Psychosis Requires Structured Questioning of Patients and Caregivers

P. Schmidt, F. Cubillos, A. Diaz, P. Wiener, S. Metz, N. Romero, C. Andersson, S. Andes, D. Fredericks, A. Shim (Miami, FL, USA)
Evaluation of postural changes and painful manifestations in caregivers of children with cerebral palsy

J. Francês Brito, M. Akkari, A. Barbosa de Sousa Junior, B. De Oliveira, A. Pinheiro Alves, O. Vieira Kishi, Jose Roberto Bentes Capeloni (Belem, Brazil)
Evaluation of the Clinical Efficacy of Motivational System Training in Parkinson’s disease

T. Chomiak, A. Watts, S. Tan, M. McKeown, B. Hu (Calgary, AB, Canada)
Evaluation of the Effect of STN-DBS on the Gastrointestinal Symptoms in Patients with Parkinson’s Disease via GIQLI

A. Yilmaz, E. Okuyucu, M. Ugur (Hatay, Turkey)
Evaluation of the interaction between safinamide and opicapone in Parkinson’s disease patients with fluctuations

J. Garcia-Caldentey, MA. Prats-Sedano, I. Legarda-Ramirez, E. Estelrich-Peyret, B. Vives-Pastor, PJ. Garcia (Palma de Mallorca, Spain)
Evaluation of the Loneliness among the Caregivers of Parkinson Disease Dementia

M. Gultekin, A. Ekinci (Kayseri, Turkey)
Evaluation of the relationship between Leucine-rich repeat kinase 2 (LRRK2) S1647T variants and smoking with risk of Parkinson’s Disease in the Singapore population

ZH. Lu, S. Ng, X.X. Huang, E. Ng, M. Parimelalagan, F. Setiawan, L. Tan, W.L. Au, K.Y. Tay, ZY. Xu, K. Prakash, E.K. Tan (Singapore)
Evaluation of visual perceptive computing for Tremor Analysis

K. Otte, F. Heinrich, T. Ellermeyer, B. Kayser, S. Mansow-Model, F. Paul, A.U. Brandt, C. Skowronek, A. Lipp, T. Schmitz-Hübsch (Berlin, Germany)
Evidence based management of Normal Pressure Hydrocephalus: Lessons and future directions

A. Mahajan, M. Macki, M. Kaur, M. Novikova, R. Shatz, J. Schwalb (Detroit, MI, USA)
Evidence for dysregulation of inflammatory mechanisms involving the NF-κB complex in the living parkinsonian brain

S. Benoit, H. Xu, R. Alexandrova, G. Kaur, B. Thiruvahindrapuram, M. Hebb (London, ON, Canada)
Evolution of diagnostic certainty and PSP-predominance types in 187 pathologically confirmed PSP patients

M. Grimm, G. Respondek, I. Piot, T. Arzberger, Y. Compta, E. Englund, L. Ferguson, E. Gelpi, A. Giese, S. Roeber, D. Irwin, W. Meissner, C. Nilsson, A. Pantelyat, A. Rajput, C. Troakes, G. Höglinger (Munich, Germany)
Evolution of Motor and Non-Motor Manifestations in Prodromal Parkinsonism

SM. Fereshtehnejad, C. Yao, A. Pelletier, J. Montplaisir, JF. Gagnon, R. Postuma (Montreal, QC, Canada)
Examination of paravertebral muscular force in camptocormia

R. Wolke, N. Margraf, J. Kuhtz-Buschbeck, G. Deuschl (Kiel, Germany)
Examining Parkinson’s disease psychosis treatment outcomes in the real world: The insyte observational study

J. Goldman, D. Fredericks, C. Heywood, A. Ryan, A. Shim (Chicago, IL, USA)
Executive dysfunctions and behavioral changes in early drug-naïve patients with Parkinson’s disease

S. Li, R. Ou, X. Yuan, H. Liu, Y. Bing, Q. Wei, W. Song, B. Cao, Y. Chen, H. Shang (Chengdu, China)
Executive Function and Frontoparietal Network Association in Freezing of Gait

E. Bayram, K. Sreenivasan, S. Banks, X. Zhuang, V. Mishra, D. Cordes, B. Bluett (Las Vegas, NV, USA)
Exercise to improve upper limb function in people with Parkinson’s disease: A systematic review

E. Proud, J. Blennerhassett, J. Tan, K. Miller, M. Morris, J. McGinley (Parkville, Australia)
Exosomal alpha synuclein secretion is beneficial for cellular models of Kufor-Rakeb syndrome

T. Tsunemi, Y. Ishiguro, A. Yoroisaka, W. Akamatsu, D. Krainc, N. Hattori (Tokyo, Japan)
Expanding the canvas of PARKIN mutations and clinical phenotypes in familial and early onset Parkinson’s disease patients

S. Pandey, L. Tomar, S. Kumar, B. Thelma (New Delhi, India)
Expanding the clinical phenotype of autosomal recessive spinocerebellar ataxia with Adult onset; a collection of case series

A. Persaud, O. Oguh (Jacksonville, FL, USA)
Expanding the clinical phenotype of BPAN: A case report

M. Boca, A. Herwadkar, C. Breen, M. Silverdale, C. Kobylecki (Salford, United Kingdom)
Expanding the NINDS Parkinson’s Disease Biomarkers Program – Utilizing a Major Biomarker Resource to Address Atypical Parkinsonisms and Related Conditions

C. Lungu, K. Arce, D. Babcock, K. David, BA. Sieber, C. Swanson-Fischer, M. Sutherland (Rockville, MD, USA)
Experimental rotenone model

X. Djakhangir, A. Ziyoda (Tashkent, Uzbekistan)
Exploration of insight competence in Huntington’s disease supplemental to a cognitive debriefing study for the FuRST2.0 rating scale

R. Fuller, P. Feigenbaum, C. Fitzer-Attas, N. La Pelle, S. Luo, C. Sampaio, G. Stebbins (Princeton, NJ, USA)
Exploring novel diffusion-derived biomarkers in Parkinson’s disease Freezing of Gait

B. Bluett, E. Bayram, S. Banks, Z. Mari, K. Sreenivasan, X. Zhuang, Z. Yang, C. Bird, D. Cordes, I. Litvan, V. Mishra (Las Vegas, NV, USA)
Exploring the neural correlates of gait asymmetry in idiopathic REM Sleep Behaviour Disorder

K. Ehgoetz Martens, E. Matar, J. Hall, M. Georgiades, M. Gilat, J. Shine, S. Lewis (Camperdown, Australia)
Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson’s disease

T. Stojkovic, E. Stefanova, I. Soldatovic, V. Markovic, I. Stankovic, F. Agosta, I. Petrovic, S. Galantucci, M. Filippi, V. Kostic (Belgrade, Serbia)
Exploring The Role of a Prescribing Pharmacist in the Management of Parkinson’s Disease

E. Wong (London, United Kingdom)
Exploring the utility of the ChulaPD intelligent Parkinson’s disease car to determine naturalistic driving ability in Parkinson’s disease patients: A pilot study of 10 patients

O. Jitkritsadakul, S. Krootjohn, P. Yanthitirat, C. Anan, R. Bhidayasiri (Bangkok, Thailand)
Explosive flurry of seizures and new-onset cortical-subcortical lesions in a patient with Wilson disease

A. Aggarwal, M. Munshi, P. Gadgil, D. Sanghvi, M. Bhatt (Mumbai, India)
Eye Movement Abnormalities Correspond to Pontine Atrophy in Wilson Disease

J. Hanuška, P. Dušek, J. Rusz, O. Ulmanová, A. Burgetová, E. Růžička (Prague, Czech Republic)
Eye movement disorders after cerebellar infaction

M. Munteanu (Bucharest, Romania)
Eye Movements during Reading in Parkinson’s Disease: A Pilot Study

J. Waldthaler, P. Tsitsi, G. Öqvist Seimyr, M. Nilsson Benfatto, P. Svenningsson (Marburg, Germany)
Eye tracking in patients with restless legs syndrome with and without augmentation – interim results of an ongoing study

P. Ellmerer, B. Heim, M. Ritter, A. Stefani, E. Brandauer, E. Holzknecht, K. Seppi, B. Högl, W. Poewe, A. Djamshidian (Innsbruck, Austria)